Tower Research Capital LLC (Trc) Adverum Biotechnologies, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.33 $13,210 - $20,520	-8,807 Reduced 92.72%	691 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.68 - $1.59 $3,932 - $9,194	-5,783 Reduced 37.84%	9,498 $15,000
Q1 2023 May 09, 2023	SELL	$0.62 - $0.85 $6,115 - $8,383	-9,863 Reduced 39.23%	15,281 $10,000
Q4 2022 Feb 10, 2023	BUY	$0.54 - $10.3 $690 - $13,163	1,278 Added 5.35%	25,144 $15,000
Q3 2022 Nov 10, 2022	BUY	$0.96 - $9.68 $15,288 - $154,163	15,926 Added 200.58%	23,866 $22,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $22,759 - $37,651	-28,098 Reduced 77.97%	7,940 $10,000
Q1 2022 May 12, 2022	BUY	$1.23 - $1.95 $35,026 - $55,530	28,477 Added 376.63%	36,038 $47,000
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $15,445 - $21,304	-8,877 Reduced 54.0%	7,561 $13,000
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $1,262 - $2,185	-607 Reduced 3.56%	16,438 $36,000
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $21,090 - $66,285	6,277 Added 58.29%	17,045 $60,000
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $24,288 - $37,666	2,623 Added 32.2%	10,768 $106,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $12,821 - $18,580	1,303 Added 19.04%	8,145 $88,000
Q3 2020 Nov 16, 2020	SELL	$10.3 - $21.64 $14,626 - $30,728	-1,420 Reduced 17.19%	6,842 $70,000
Q2 2020 Aug 13, 2020	BUY	$8.53 - $25.64 $70,474 - $211,837	8,262 New	8,262 $173,000
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $21,266 - $43,492	-2,665 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$5.12 - $12.22 $71,050 - $169,576	-13,877 Reduced 83.89%	2,665 $31,000
Q3 2019 Nov 05, 2019	BUY	$5.24 - $15.89 $86,680 - $262,852	16,542 New	16,542 $90,000
Q2 2019 Aug 13, 2019	SELL	$5.1 - $11.89 $8,930 - $20,819	-1,751 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$3.03 - $6.02 $22,576 - $44,855	-7,451 Reduced 80.97%	1,751 $9,000
Q4 2018 Feb 14, 2019	BUY	$2.87 - $5.92 $26,409 - $54,475	9,202 New	9,202 $29,000
Q3 2018 Nov 13, 2018	SELL	$4.5 - $7.6 $846 - $1,428	-188 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$5.3 - $6.9 $39,326 - $51,198	-7,420 Reduced 97.53%	188 $1,000
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $27,769 - $60,483	7,608 New	7,608 $44,000
Q4 2017 Feb 09, 2018	SELL	$2.85 - $3.95 $10,314 - $14,295	-3,619 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $8,866 - $13,209	3,619	3,619 $13,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account